Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Net Income Scaling
Trending higher, above historical average, slight contraction.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-18.61M
↑ 16% above average
Average (9y)
$-22.11M
Historical baseline
Range
High:$33.57M
Low:$-46.99M
CAGR
-9.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-18.61M | +13.4% |
| 2023 | $-21.49M | +18.2% |
| 2022 | $-26.27M | +38.9% |
| 2021 | $-43.02M | -108.3% |
| 2020 | $-20.65M | -76.4% |
| 2019 | $-11.71M | +74.5% |
| 2018 | $-45.99M | -130.2% |
| 2017 | $-19.98M | -159.5% |
| 2016 | $33.57M | +171.4% |
| 2015 | $-46.99M | - |